AstraZeneca Reports Results of Imfinzi (durvalumab) and Imfinzi + Tremelimumab in P-III POSEIDON Study as 1L Treatment for Stage IV Non-Small Cell Lung Cancer

Published: May 7, 2021 | Tags: AstraZeneca, Imfinzi, durvalumab, Tremelimumab, P-III, POSEIDON Study, Stage IV Non-Small Cell Lung Cancer

Merck and Fusion Pharmaceuticals Enter into a Clinical Collaboration for FPI-1434 + Keytruda (pembrolizumab) to Treat Solid Tumors Expressing IGF-1R

Published: May 7, 2021 | Tags: Merck, Fusion Pharmaceuticals, FPI-1434, Keytruda, pembrolizumab, Solid Tumors, IGF-1R

BMS Signs a Research Collaboration with DarwinHealth to Discover Novel Cancer Target Initiative

Published: May 7, 2021 | Tags: BMS, DarwinHealth, Novel Cancer Target Initiative

BeiGene and Asieris Enter into Clinical Collaboration for APL-1202 + Tislelizumab to Treat Muscle Invasive Bladder Cancer

Published: May 7, 2021 | Tags: BeiGene, Asieris, APL-1202, Tislelizumab, Muscle Invasive Bladder Cancer

AbCellera Signs a Multi-Target Collaboration with Amgen to Develop Bispecific Antibodies for the Treatment of Diabetic Retinopathy

Published: May 7, 2021 | Tags: AbCellera, Amgen, Bispecific Antibodies, Diabetic Retinopathy

Merck and Eisai Receive the US FDA's Priority Review for Keytruda (pembrolizumab) + Lenvima (lenvatinib) Applications to Treat Advanced Renal Cell Carcinoma and Endometrial Carcinoma

Published: May 7, 2021 | Tags: Merck, Eisai, US, FDA, Priority Review, Keytruda, pembrolizumab, Lenvima, Lenvatinib, Applications, Advanced Renal Cell Carcinoma, Endometrial Carcinoma

Amgen Reports the US FDA's Acceptance of sNDA for Review of Otezla (apremilast) to Treat Mild-To-Moderate Plaque Psoriasis

Published: May 6, 2021 | Tags: Amgen, US, FDA, Acceptance, sNDA, Review, Otezla, apremilast, Plaque Psoriasis

Roche's Ab Cocktail (Casirivimab and Imdevimab) Receives EUA to Treat COVID-19 in India

Published: May 6, 2021 | Tags: Roche, Ab Cocktail, Casirivimab, Imdevimab, EUA, COVID-19

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

Published: May 6, 2021 | Tags: Sanofi, Stanford Medicine, Accelerate, Immunology Research

Medtronic Launches CareGuidePro App for Managing Spinal Cord Stimulation

Published: May 6, 2021 | Tags: Medtronic, CareGuidePro App, Managing, Spinal Cord Stimulation

Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test

Published: May 6, 2021 | Tags: Phenomix, Mayo Clinic, AI-Powered, Obesity, Phenotype Blood Test

GSK's Benlysta (belimumab) Receives EC's Approval for the Treatment of Active Lupus Nephritis

Published: May 6, 2021 | Tags: GSK, Benlysta, belimumab, EC, Approval, Active Lupus Nephritis

Exelixis Acquires GamaMabs' Oncology Antibody Program to Expand its Biotherapeutics Portfolio

Published: May 5, 2021 | Tags: Exelixis, GamaMabs, Oncology Antibody Program, Biotherapeutics Portfolio

ProQR Therapeutics Signs an Exclusive Worldwide License Agreement with Yarrow to Develop Therapies for Non-Ophthalmic Target

Published: May 5, 2021 | Tags: ProQR Therapeutics, Yarrow, Therapies, Non-Ophthalmic Target

AbCellera to Initiate Clinical Trial of LY-CoV1404 Against Viral Variants of COVID 19

Published: May 5, 2021 | Tags: AbCellera, Clinical Trial, LY-CoV1404, Against, Viral Variants, COVID 19

Amgen Launches Amgevita (biosimilar, adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases in Canada

Published: May 5, 2021 | Tags: Amgen, Amgevita, biosimilar, adalimumab, Multiple Chronic Inflammatory Diseases

Roche's Tecentriq Receives EC's Approval as 1L Treatment for Metastatic Non-Small Cell Lung Cancer

Published: May 5, 2021 | Tags: Roche, Tecentriq, EC, Approval, Metastatic Non-Small Cell Lung Cancer

Athenex to Acquire Kuur Therapeutics for ~$185M

Published: May 5, 2021 | Tags: Athenex, Kuur Therapeutics, ~$185M

Vaxart Reports News Data of VXA-CoV2-1 (Oral COVID-19 Vaccine) in P-I Trial Against Other Coronaviruses

Published: May 4, 2021 | Tags: Vaxart, VXA-CoV2-1, Oral COVID-19 Vaccine, P-I, Trial, Against, Other Coronaviruses

Novavax Reports the Pediatric Expansion for P-III Clinical Trial of NVX-CoV2373 Against COVID-19

Published: May 4, 2021 | Tags: Novavax, Pediatric Expansion, P-III, Clinical Trial, NVX-CoV2373, COVID-19

BMS Presents Clinical and RWE Data of Mavacamten for Obstructive Hypertrophic Cardiomyopathy at ACC 2021

Published: May 4, 2021 | Tags: BMS, Mavacamten, Obstructive Hypertrophic Cardiomyopathy, ACC 2021

Sandoz Initiates Patient Enrolment of Proposed Biosimilar Aflibercept in P-III MYLIGHT Study for Neovascular Age-Related Macular Degeneration

Published: May 4, 2021 | Tags: Sandoz, Proposed, Biosimilar, Aflibercept, P-III, MYLIGHT Study,  Neovascular Age-Related Macular Degeneration

Labcorp to Acquire Myriad's Vectra Testing Business for $150M

Published: May 4, 2021 | Tags: Labcorp, Myriad, Vectra Testing Business, $150M

Roivant Going Public Via MAAC SPAC Merger for ~$7.3B

Published: May 4, 2021 | Tags: Roivant, MAAC SPAC, Merger,~$7.3B

Eli Lilly and Incyte Present New Data of Olumiant (baricitinib) in P-III BREEZE-AD5 Trial Moderate to Severe Atopic Dermatitis at AAD2021

Published: May 3, 2021 | Tags: Eli Lilly, Incyte, Olumiant, baricitinib, P-III, BREEZE-AD5 Trial, Atopic Dermatitis, AAD2021

Guardant Health Reports Results of Blood-Only Liquid Biopsy Test Predicting Risk of Colorectal Cancer Recurrence

Published: May 3, 2021 | Tags: Guardant Health, Blood-Only, Liquid Biopsy Test, Colorectal Cancer Recurrence

Sobi and Hellenic Institute Report Results of Anakinra in P-III SAVE-MORE Study for Hospitalized Patients with COVID-19 Pneumonia

Published: May 3, 2021 | Tags: Sobi, Hellenic Institute, Anakinra, P-III, SAVE-MORE Study, COVID-19 Pneumonia

Novartis Presents Results of Beovu (brolucizumab -dbll) in P-III KESTREL and KITE Studies for Diabetic Macular Edema at ARVO2021

Published: May 3, 2021 | Tags: Novartis, Beovu, brolucizumab -dbll, P-III, KESTREL, KITE Studies,  Diabetic Macular Edema, ARVO2021

Samsung Bioepis Presents Results of SB11 (proposed biosimilar ranibizumab) at ARVO 2021

Published: May 3, 2021 | Tags: Samsung Bioepis, SB11, biosimilar, ranibizumab, ARVO 2021

AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Approval for Chronic Kidney Disease

Published: May 3, 2021 | Tags: AstraZeneca, Farxiga, dapagliflozin, US, FDA, Approval, Chronic Kidney Disease
Related Post: PharmaShots Weekly Snapshots (Apr 26 - 30, 2021)